Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
3vzd | UUL | Sphingosine kinase 1 | 2.7.1.91 |
PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
---|---|---|---|---|---|
3vzd | UUL | Sphingosine kinase 1 | 2.7.1.91 | 1.000 | |
3vzc | UUL | Sphingosine kinase 1 | 2.7.1.91 | 0.683 | |
4l02 | 1V2 | Sphingosine kinase 1 | 2.7.1.91 | 0.629 | |
1pp9 | SMA | Cytochrome b | / | 0.483 | |
3bus | SAH | Demethylrebeccamycin-D-glucose O-methyltransferase | / | 0.472 | |
1qxl | FR8 | Adenosine deaminase | 3.5.4.4 | 0.471 | |
3p9t | TCL | Repressor | / | 0.466 | |
4jkt | 04A | Glutaminase kidney isoform, mitochondrial | 3.5.1.2 | 0.466 | |
4tzt | 468 | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.466 | |
1uml | FR4 | Adenosine deaminase | 3.5.4.4 | 0.464 | |
4anm | WUL | Casein kinase II subunit alpha | 2.7.11.1 | 0.464 | |
1diu | BDM | Dihydrofolate reductase | 1.5.1.3 | 0.463 | |
3nwl | NDP | Catalase | 1.11.1.6 | 0.463 | |
3cxh | SMA | Cytochrome b | / | 0.462 | |
3fco | IIG | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.462 | |
3w0a | DS5 | Vitamin D3 receptor | / | 0.462 | |
1o5r | FR9 | Adenosine deaminase | 3.5.4.4 | 0.461 | |
3w0c | 6DS | Vitamin D3 receptor | / | 0.461 | |
1bvr | THT | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.460 | |
2om9 | AJA | Peroxisome proliferator-activated receptor gamma | / | 0.460 | |
5cp8 | TCU | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.460 | |
7cat | NDP | Catalase | 1.11.1.6 | 0.460 | |
1fvp | FMA | Non-fluorescent flavoprotein | / | 0.459 | |
1p44 | GEQ | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.458 | |
1ygk | RRC | Pyridoxal kinase | 2.7.1.35 | 0.458 | |
5iub | CLR | Adenosine receptor A2a | / | 0.458 | |
1cjc | FAD | NADPH:adrenodoxin oxidoreductase, mitochondrial | 1.18.1.6 | 0.456 | |
1dgh | NDP | Catalase | 1.11.1.6 | 0.456 | |
3czr | 3CZ | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.456 | |
4j6c | STR | Cytochrome P450 monooxygenase | / | 0.456 | |
4qzu | RTL | Retinol-binding protein 2 | / | 0.456 | |
2ilt | NN1 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.455 | |
4plp | NAD | Homospermidine synthase | 2.5.1.44 | 0.455 | |
5epe | SAH | Uncharacterized protein | / | 0.455 | |
4bfp | SWY | Tankyrase-2 | 2.4.2.30 | 0.454 | |
8cat | NDP | Catalase | 1.11.1.6 | 0.454 | |
1qnf | HDF | Deoxyribodipyrimidine photo-lyase | 4.1.99.3 | 0.453 | |
2q9f | C3S | Cholesterol 24-hydroxylase | / | 0.453 | |
3vt3 | VDX | Vitamin D3 receptor | / | 0.453 | |
4cnj | FAD | L-amino acid oxidase | / | 0.453 | |
4tzk | 641 | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.453 | |
1ezv | SMA | Cytochrome b | / | 0.452 | |
1ndz | FR5 | Adenosine deaminase | 3.5.4.4 | 0.452 | |
2agv | TG1 | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 3.6.3.8 | 0.452 | |
3u8h | BHP | Phospholipase A2, membrane associated | / | 0.452 | |
4i9i | 1DY | Tankyrase-1 | 2.4.2.30 | 0.452 | |
4j6d | TES | Cytochrome P450 monooxygenase | / | 0.452 | |
1fm9 | 570 | Peroxisome proliferator-activated receptor gamma | / | 0.451 | |
1o1v | TCH | Gastrotropin | / | 0.451 | |
2w98 | P1Z | Prostaglandin reductase 2 | 1.3.1.48 | 0.451 | |
4anv | 751 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.451 | |
4wuo | NAD | 3-isopropylmalate dehydrogenase | 1.1.1.85 | 0.451 | |
1kvo | OAP | Phospholipase A2, membrane associated | / | 0.450 | |
3gkj | HC3 | Niemann-Pick C1 protein | / | 0.450 | |
1e1l | FAD | NADPH:adrenodoxin oxidoreductase, mitochondrial | 1.18.1.6 | 0.449 | |
1ma0 | NAD | Alcohol dehydrogenase class-3 | 1.1.1.1 | 0.449 | |
1rkg | VD1 | Vitamin D3 receptor | / | 0.449 | |
4jbt | ASD | Cytochrome P450 monooxygenase | / | 0.449 | |
1zgy | BRL | Peroxisome proliferator-activated receptor gamma | / | 0.448 | |
2ovh | AS0 | Progesterone receptor | / | 0.448 | |
3ant | S82 | Bifunctional epoxide hydrolase 2 | 3.3.2.10 | 0.448 | |
3juh | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.448 | |
4trj | 665 | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.448 | |
1e1k | FAD | NADPH:adrenodoxin oxidoreductase, mitochondrial | 1.18.1.6 | 0.447 | |
3cx5 | SMA | Cytochrome b | / | 0.447 | |
3irx | UDR | Gag-Pol polyprotein | 2.7.7.49 | 0.447 | |
4g67 | SAH | Uncharacterized ACR, COG1565 superfamily | / | 0.447 | |
4nmd | FDA | Bifunctional protein PutA | / | 0.447 | |
2xvu | 9DN | Serum albumin | / | 0.446 | |
3otq | MZL | Bifunctional epoxide hydrolase 2 | 3.3.2.10 | 0.446 | |
3t7x | 4SH | Endothiapepsin | 3.4.23.22 | 0.446 | |
3zk5 | Z18 | Cytochrome P450 monooxygenase PikC | / | 0.446 | |
1d3g | BRE | Dihydroorotate dehydrogenase (quinone), mitochondrial | 1.3.5.2 | 0.445 | |
1olm | VTQ | SEC14-like protein 2 | / | 0.445 | |
1opb | RET | Retinol-binding protein 2 | / | 0.445 | |
1yin | CM3 | Estrogen receptor | / | 0.445 | |
2hcd | BIV | Vitamin D3 receptor A | / | 0.445 | |
2o4r | VD5 | Vitamin D3 receptor | / | 0.445 | |
4kf1 | HT5 | Aryldialkylphosphatase | 3.1.8.1 | 0.445 | |
4lxh | C1E | Alpha/beta hydrolase fold | / | 0.445 | |
4mih | FAD | Pyranose 2-oxidase | 1.1.3.10 | 0.445 | |
4xrg | NAD | Homospermidine synthase | 2.5.1.44 | 0.445 | |
5ab6 | CAA | Nonspecific lipid-transfer protein, putative | / | 0.445 | |
5iu8 | 6DZ | Adenosine receptor A2a | / | 0.445 | |
1h36 | R88 | Squalene--hopene cyclase | 4.2.1.129 | 0.444 | |
1n4h | REA | Nuclear receptor ROR-beta | / | 0.444 | |
1sui | FRE | Caffeoyl-CoA O-methyltransferase | 2.1.1.104 | 0.444 | |
4h4o | 506 | Gag-Pol polyprotein | 2.7.7.49 | 0.444 | |
5k2b | ZMA | Adenosine receptor A2a | / | 0.444 | |
1p91 | SAM | 23S rRNA (guanine(745)-N(1))-methyltransferase | / | 0.443 | |
2bel | CBO | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.443 | |
2ivp | ATP | tRNA N6-adenosine threonylcarbamoyltransferase | / | 0.443 | |
2ylt | FAD | Phenylacetone monooxygenase | 1.14.13.92 | 0.443 | |
3a78 | 3EV | Vitamin D3 receptor | / | 0.443 | |
3ar4 | TG1 | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 3.6.3.8 | 0.443 | |
1dgf | NDP | Catalase | 1.11.1.6 | 0.442 | |
3pww | ROC | Endothiapepsin | 3.4.23.22 | 0.442 | |
5jtb | ZMA | Adenosine receptor A2a | / | 0.442 | |
1fp1 | HCC | Isoliquiritigenin 2'-O-methyltransferase | / | 0.441 | |
1ppj | ANY | Cytochrome b | / | 0.441 | |
2fzm | FAD | Bifunctional protein PutA | 1.5.5.2 | 0.441 | |
2phk | ATP | Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | 2.7.11.19 | 0.441 | |
3cwk | REA | Cellular retinoic acid-binding protein 2 | / | 0.441 | |
3d3e | D3E | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.441 | |
3h6k | 33T | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.441 | |
3ojx | NAP | NADPH--cytochrome P450 reductase | / | 0.441 | |
4fv7 | E94 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.441 | |
4irn | FAD | AnaB | / | 0.441 | |
4mq2 | 2C4 | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 2.7.12.1 | 0.441 | |
4xsr | UPG | Alr3699 protein | / | 0.441 | |
1fmj | RTL | Retinol dehydratase | / | 0.440 | |
1sj0 | E4D | Estrogen receptor | / | 0.440 | |
2ham | C33 | Vitamin D3 receptor | / | 0.440 | |
2vnh | FAD | NADPH:ferredoxin reductase | / | 0.440 | |
2zb8 | IMN | Prostaglandin reductase 2 | 1.3.1.48 | 0.440 | |
3kpz | ZNE | Vitamin D3 receptor | / | 0.440 | |
4bca | FAD | Alkyldihydroxyacetonephosphate synthase, peroxisomal | 2.5.1.26 | 0.440 | |
4eev | L1X | Hepatocyte growth factor receptor | 2.7.10.1 | 0.440 | |
4xq9 | NAD | Homospermidine synthase | 2.5.1.44 | 0.440 | |
5ab7 | MLC | Nonspecific lipid-transfer protein, putative | / | 0.440 | |
5hs1 | VOR | Lanosterol 14-alpha demethylase | / | 0.440 |